Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary ZIOPHARM Oncology Accomplishes Key Clinical Development Milestone
-- Receives FDA Clearance to Initiate ZIO-101 Phase I/II Myeloma Trial --
View HTML
Toggle Summary ZIOPHARM Oncology Announces ZIO-101 Data Published in Blood View HTML
Toggle Summary ZIOPHARM Oncology Announces ZIO-201 ASH Abstract Publication View HTML
Toggle Summary ZIOPHARM Oncology Announces ZIO-102 Data Presented at AACR-NCI-EORTC International Conference View HTML
Toggle Summary ZIOPHARM Oncology Announces ZIO-101 Phase I Data Presented at AACR-NCI-EORTC International Conference
Novel Organic Arsenic Evidences Both Safety and Activity
View HTML
Toggle Summary ZIOPHARM Oncology to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference View HTML
Toggle Summary ZIOPHARM Oncology to Present at MASS Opportunities Partnering Forum View HTML
Toggle Summary ZIOPHARM Oncology to Present at C.E. Unterberg, Towbin Life Sciences Conference View HTML
Toggle Summary ZIOPHARM Oncology to Present at Bio Investor Forum View HTML
Toggle Summary ZIOPHARM Oncology, Inc. Announces Symbol Change to ZIOP
ZIOPHARM Oncology, Inc. Announces Symbol Change to ZIOP New York, NY - September 26, 2005 - ZIOPHARM Oncology, Inc. (OTC BB: ZIOP) announced today its ticker symbol has changed from "ESWB" to "ZIOP". The symbol change, which is effective as of the opening of business today, is a result of the
View HTML